Y Intercept Hong Kong Ltd Makes New Investment in Teladoc Health, Inc. $TDOC

Y Intercept Hong Kong Ltd bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 312,560 shares of the health services provider’s stock, valued at approximately $2,722,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in TDOC. Golden State Wealth Management LLC boosted its stake in Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock worth $27,000 after purchasing an additional 1,690 shares during the last quarter. National Bank of Canada FI boosted its stake in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC acquired a new stake in Teladoc Health during the 1st quarter worth $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Teladoc Health during the 1st quarter worth $50,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Teladoc Health by 8,192.0% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock worth $72,000 after purchasing an additional 8,192 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on TDOC shares. Zacks Research upgraded Teladoc Health from a “hold” rating to a “strong-buy” rating in a report on Friday, October 10th. Evercore ISI reduced their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a report on Thursday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. Mizuho started coverage on Teladoc Health in a report on Friday, July 25th. They set a “neutral” rating and a $10.00 price target on the stock. Finally, Citigroup lifted their price target on Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a report on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $9.89.

Teladoc Health Stock Up 6.3%

Shares of TDOC opened at $8.75 on Friday. The firm has a market cap of $1.55 billion, a P/E ratio of -6.84 and a beta of 1.90. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company’s 50-day moving average price is $8.21 and its 200 day moving average price is $7.70. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.05. The firm had revenue of $626.44 million for the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.49%. Teladoc Health’s revenue was down 2.2% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.